Revenue | ₹100.61Cr |
Net Profits | ₹0.57Cr |
Net Profit Margins | 0.57% |
Aarey Drugs & Pharmaceuticals Ltd’s revenue fell -25.18% since last year same period to ₹100.61Cr in the Q3 2025-2026. On a quarterly growth basis, Aarey Drugs & Pharmaceuticals Ltd has generated 18.43% jump in its revenue since last 3-months.
Aarey Drugs & Pharmaceuticals Ltd’s net profit fell -20.83% since last year same period to ₹0.57Cr in the Q3 2025-2026. On a quarterly growth basis, Aarey Drugs & Pharmaceuticals Ltd has generated -44.12% fall in its net profits since last 3-months.
Aarey Drugs & Pharmaceuticals Ltd’s net profit margin jumped 5.81% since last year same period to 0.57% in the Q3 2025-2026. On a quarterly growth basis, Aarey Drugs & Pharmaceuticals Ltd has generated -52.82% fall in its net profit margins since last 3-months.
The revenue for Aarey Drugs & Pharmaceuticals Ltd in the Q3 results 2025 was ₹100.61Cr.
The net profit for Aarey Drugs & Pharmaceuticals Ltd in the Q3 results 2025 was ₹0.57Cr.
The net profit margin for Aarey Drugs & Pharmaceuticals Ltd in the Q3 results 2025 was 0.57%.
The revenue for Aarey Drugs & Pharmaceuticals Ltd in the Q3 results 2024 was ₹134.47Cr.
The net profit for Aarey Drugs & Pharmaceuticals Ltd in the Q3 results 2024 was ₹0.72Cr.
The net profit margin for Aarey Drugs & Pharmaceuticals Ltd in the Q3 results 2024 was 0.54%.